These medications , copyright and Wegovy, represent a significant shift in how treating diabetes and, increasingly, obesity . They work as GLP-1 receptor agonists , mimicking the action of a bodily hormone https://dirstop.com/story28971212/copyright-semaglutide-understanding-the-glp-1-breakthrough